John T Henderson - Net Worth and Insider Trading

John T Henderson Net Worth

The estimated net worth of John T Henderson is at least $4 Million dollars as of 2024-03-28. John T Henderson is the Director of Cytokinetics Inc and owns about 42,715 shares of Cytokinetics Inc (CYTK) stock worth over $3 Million. John T Henderson is also the Director of Myriad Genetics Inc and owns about 66,403 shares of Myriad Genetics Inc (MYGN) stock worth over $1 Million. Details can be seen in John T Henderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John T Henderson has not made any transactions after 2024-02-14 and currently still holds the listed stock(s).

Transaction Summary of John T Henderson

To

John T Henderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John T Henderson owns 3 companies in total, including Cytokinetics Inc () , Myriad Genetics Inc () , and Myrexis Inc () .

Click here to see the complete history of John T Henderson’s form 4 insider trades.

Insider Ownership Summary of John T Henderson

Ticker Comapny Transaction Date Type of Owner
Cytokinetics Inc 2024-02-14 director
Myriad Genetics Inc 2019-11-07 director
Myrexis Inc 2013-01-18 director

John T Henderson Latest Holdings Summary

John T Henderson currently owns a total of 2 stocks. Among these stocks, John T Henderson owns 42,715 shares of Cytokinetics Inc (CYTK) as of February 14, 2024, with a value of $3 Million and a weighting of 67.9%. John T Henderson also owns 66,403 shares of Myriad Genetics Inc (MYGN) as of November 7, 2019, with a value of $1 Million and a weighting of 32.1%.

Latest Holdings of John T Henderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2024-02-14 42,715 70.11 2,994,749
MYGN Myriad Genetics Inc 2019-11-07 66,403 21.32 1,415,712

Holding Weightings of John T Henderson


John T Henderson Form 4 Trading Tracker

According to the SEC Form 4 filings, John T Henderson has made a total of 10 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Cytokinetics Inc is the sale of 5,000 shares on February 14, 2024, which brought John T Henderson around $382,400.

According to the SEC Form 4 filings, John T Henderson has made a total of 1 transactions in Myriad Genetics Inc (MYGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Myriad Genetics Inc is the acquisition of 7,000 shares on November 7, 2019, which cost John T Henderson around $164,220.

Insider Trading History of John T Henderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John T Henderson Trading Performance

GuruFocus tracks the stock performance after each of John T Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John T Henderson is 6.06%. GuruFocus also compares John T Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by John T Henderson within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John T Henderson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John T Henderson

Average Relative Return

14.96%

Average relative return per transaction

Outperforming Transactions

60%

3 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 4.6 6.06 27.39 14.96 33.82 15.75
Relative Return to S&P 500(%) 1.65 -0.07 23.13 -1.56 16.42 4.9

John T Henderson Ownership Network

Ownership Network List of John T Henderson

No Data

Ownership Network Relation of John T Henderson


John T Henderson Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

John T Henderson is the director of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc () Insider Trades Summary

Over the past 18 months, John T Henderson made 4 insider transaction in Cytokinetics Inc () with a net sale of 16,624. Other recent insider transactions involving Cytokinetics Inc () include a net sale of 342,500 shares made by Robert I Blum , a net sale of 124,583 shares made by Fady Ibraham Malik , and a net sale of 23,020 shares made by Wendall Wierenga .

In summary, during the past 3 months, insiders sold 95,783 shares of Cytokinetics Inc () in total and bought 0 shares, with a net sale of 95,783 shares. During the past 18 months, 531,065 shares of Cytokinetics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 531,065 shares.

Cytokinetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

John T Henderson Mailing Address

Above is the net worth, insider trading, and ownership report for John T Henderson. You might contact John T Henderson via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.

Discussions on John T Henderson

No discussions yet.